Denali Therapeutics  logo
Denali Therapeutics DNLI
$ 27.44 0.83%

Quarterly report 2024-Q2
added 08-01-2024

report update icon

Denali Therapeutics Operating Income 2011-2024 | DNLI

Annual Operating Income Denali Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-341 M -296 M 62.7 M -213 M -46.4 M -90.1 M -87.4 M - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
62.7 M -341 M -144 M

Quarterly Operating Income Denali Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-117 M -118 M - -114 M 170 M -121 M - -107 M -61.4 M -66.5 M - -85.6 M -61.8 M -71.2 M - -60.1 M -61.3 M -60 M -57.8 M -50.2 M -62.8 M -42.5 M 74.7 M -38 M -57.4 M -25.7 M -23.5 M -22.3 M -22.6 M -21.7 M - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
170 M -121 M -49.4 M